NCT04388839 2025-11-26
Evolutionary Therapy for Rhabdomyosarcoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT01222715 2017-05-05
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003234 2014-07-28
Vinorelbine in Treating Children With Recurrent or Refractory Cancers
Children's Oncology Group
Phase 2 Completed
NCT00134641 2007-12-21
Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas
Dana-Farber Cancer Institute
Phase 2 Completed